<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35812094</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.</ArticleTitle><Pagination><StartPage>914411</StartPage><MedlinePgn>914411</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">914411</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2022.914411</ELocationID><Abstract><AbstractText>In this article we review complications to the peripheral nervous system that occur as a consequence of viral infections, with a special focus on complications of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We discuss neuromuscular complications in three broad categories; the direct consequences of viral infection, autoimmune neuromuscular disorders provoked by viral infections, and chronic neurodegenerative conditions which have been associated with viral infections. We also include discussion of neuromuscular disorders that are treated by immunomodulatory therapies, and how this affects patient susceptibility in the current context of the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 is associated with direct consequences to the peripheral nervous system via presumed direct viral injury (dysgeusia/anosmia, myalgias/rhabdomyolysis, and potentially mononeuritis multiplex) and autoimmunity (Guillain Barr&#xe9; syndrome and variants). It has important implications for people receiving immunomodulatory therapies who may be at greater risk of severe outcomes from COVID-19. Thus far, chronic post-COVID syndromes (a.k.a: long COVID) also include possible involvement of the neuromuscular system. Whether we may observe neuromuscular degenerative conditions in the longer term will be an important question to monitor in future studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Jacob, Kapadia, Soule, Luo, Schellenberg, Douville and Pfeffer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapadia</LastName><ForeName>Ronak</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soule</LastName><ForeName>Tyler</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schellenberg</LastName><ForeName>Kerri L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douville</LastName><ForeName>Ren&#xe9;e N</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Division of Neurodegenerative Disorders, Department of Biology, Albrechtsen St. Boniface Research Centre, University of Winnipeg, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeffer</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Genetics, Alberta Child Health Research Institute, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Guillain-Barre syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autoimmune disease</Keyword><Keyword MajorTopicYN="N">neuromuscular disease (NMD)</Keyword><Keyword MajorTopicYN="N">viral disease</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>11</Day><Hour>3</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35812094</ArticleId><ArticleId IdType="pmc">PMC9263266</ArticleId><ArticleId IdType="doi">10.3389/fneur.2022.914411</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. (2020) 87:18&#x2013;22. 10.1016/j.bbi.2020.03.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E, Newcombe V, Michell A, Thornton R, Grainger A, Anwar F, et al. . Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19. J Neurol. (2020) 268:2685&#x2013;9. 10.1007/s00415-020-10321-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10321-8</ArticleId><ArticleId IdType="pmc">PMC7690651</ArticleId><ArticleId IdType="pubmed">33244712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitry MA, Collins LK, Kazam JJ, Kaicker S, Kovanlikaya A. Parsonage-turner syndrome associated with SARS-CoV2 (COVID-19) infection. Clin Imaging. (2021) 72:8&#x2013;10. 10.1016/j.clinimag.2020.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinimag.2020.11.017</ArticleId><ArticleId IdType="pmc">PMC7654330</ArticleId><ArticleId IdType="pubmed">33190028</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazzara MB, Modoni A, Bizzarro A, Lauria A, Ciciarello F, Pais C, et al. . COVID-19 atypical Parsonage-Turner syndrome: a case report. BMC Neurol. (2022) 22:96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924565</ArticleId><ArticleId IdType="pubmed">35296278</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosla SG, Nylen ES, Khosla R. Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series. J Investi Med High Impact Case Rep. (2020) 8:2324709620984603. 10.1177/2324709620984603</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2324709620984603</ArticleId><ArticleId IdType="pmc">PMC7780065</ArticleId><ArticleId IdType="pubmed">33371733</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Xu L, Luo T, Wu F, Zhao B, Li X. The etiology of Bell's palsy: a review. J Neurol. (2020) 267:1896&#x2013;905. 10.1007/s00415-019-09282-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09282-4</ArticleId><ArticleId IdType="pmc">PMC7320932</ArticleId><ArticleId IdType="pubmed">30923934</ArticleId></ArticleIdList></Reference><Reference><Citation>Savoldi F, Kaufmann TJ, Flanagan EP, Toledano M, Weinshenker BG. Elsberg syndrome: A rarely recognized cause of cauda equina syndrome and lower thoracic myelitis. Neurol Neuroimmunol Neuroinflam. (2017) 4:e355. 10.1212/NXI.0000000000000355</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000355</ArticleId><ArticleId IdType="pmc">PMC5427668</ArticleId><ArticleId IdType="pubmed">28534040</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma P, Costa A, Duro R, Neves N, Abreu C, Sarmento A. Mononeuritis multiplex: an uncommon neurological manifestation of cytomegalovirus reactivation in an HIV-infected patient. BMC Infect Dis. (2018) 18:554. 10.1186/s12879-018-3501-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3501-2</ArticleId><ArticleId IdType="pmc">PMC6233374</ArticleId><ArticleId IdType="pubmed">30419847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadley GR, Gayle JA, Ripoll J, Jones MR, Argoff CE, Kaye RJ, et al. . Post-herpetic Neuralgia: a Review. Curr Pain Headache Rep. (2016) 20:17. 10.1007/s11916-016-0548-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-016-0548-x</ArticleId><ArticleId IdType="pubmed">26879875</ArticleId></ArticleIdList></Reference><Reference><Citation>Niesvizky-Kogan I, Greca I, Gambhir HS. Varicella zoster presenting as cranial polyneuropathy. Am J Emerg Med. (2019) 37(3):564.e5&#x2013;564.e6. 10.1016/j.ajem.2018.12.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2018.12.025</ArticleId><ArticleId IdType="pubmed">30583817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr J, Macartney K, Britton PN. Influenza-associated myositis: a single-centre, 5-year retrospective study. Eur J Pediatr. (2021) 180:577&#x2013;84. 10.1007/s00431-020-03835-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-020-03835-w</ArticleId><ArticleId IdType="pubmed">33095429</ArticleId></ArticleIdList></Reference><Reference><Citation>Prior DE, Song N, Cohen JA. Neuromuscular diseases associated with human immunodeficiency virus infection. J Neurol Sci. (2018) 387:27&#x2013;36. 10.1016/j.jns.2018.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2018.01.016</ArticleId><ArticleId IdType="pubmed">29571868</ArticleId></ArticleIdList></Reference><Reference><Citation>Dartevel A, Colombe B, Bosseray A, Larrat S, Sarrot-Reynauld F, Belbezier A, et al. . Hepatitis E and neuralgic amyotrophy: Five cases and review of literature. J Clin Virol. (2015) 69:156&#x2013;64. 10.1016/j.jcv.2015.06.091</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.06.091</ArticleId><ArticleId IdType="pubmed">26209399</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis. (1996) 22:642&#x2013;9. 10.1093/clinids/22.4.642</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/22.4.642</ArticleId><ArticleId IdType="pubmed">8729203</ArticleId></ArticleIdList></Reference><Reference><Citation>Poels PJ, Ewals JA, Joosten EM, van Loon AM. Rhabdomyolysis associated with simultaneous Epstein-Barr virus infection and isolation of echovirus 6 from muscle: a dual infection. J Neurol Neurosurg Psychiatry. (1989) 52:412&#x2013;4. 10.1136/jnnp.52.3.412</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.52.3.412</ArticleId><ArticleId IdType="pmc">PMC1032425</ArticleId><ArticleId IdType="pubmed">2538573</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosti E, Giorgianni A, D'Amore F, Vinacci G, Balbi S, Locatelli D. Is Guillain-Barr&#xe8; syndrome triggered by SARS-CoV-2? Case report and literature review. Neurol Sci. (2021) 42:607&#x2013;12. 10.1007/s10072-020-04553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04553-9</ArticleId><ArticleId IdType="pmc">PMC7343406</ArticleId><ArticleId IdType="pubmed">32643136</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammed L, Baheerathan A, Cao M, Leite MI, Viegas S. MuSK antibody&#x2013;associated myasthenia gravis with SARS-CoV-2 infection: a case report. Ann Intern Med. (2021) 174:872&#x2013;3. 10.7326/L20-1298</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-1298</ArticleId><ArticleId IdType="pmc">PMC7808439</ArticleId><ArticleId IdType="pubmed">33428437</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, Wang W, Jacobs BC, Qiao B, Chen M, Liu D, et al. . Antecedent infections in Guillain-Barr&#xe9; syndrome: a single-center, prospective study. Ann Clin Transl Neurol. (2019) 6:2510&#x2013;7. 10.1002/acn3.50946</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50946</ArticleId><ArticleId IdType="pmc">PMC6917331</ArticleId><ArticleId IdType="pubmed">31714025</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann HC, Hartung HP, Kieseier BC, Hughes RAC. Guillain-Barr&#xe9; syndrome after exposure to influenza virus. Lancet Infect Dis. (2010) 10:643&#x2013;51. 10.1016/S1473-3099(10)70140-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70140-7</ArticleId><ArticleId IdType="pubmed">20797646</ArticleId></ArticleIdList></Reference><Reference><Citation>Leis AA, Szatmary G, Ross MA, Stokic DS. West nile virus infection and myasthenia gravis. Muscle Nerve. (2014) 49:26&#x2013;9. 10.1002/mus.23869</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23869</ArticleId><ArticleId IdType="pubmed">23559196</ArticleId></ArticleIdList></Reference><Reference><Citation>Parra B, Lizarazo J, Jim&#xe9;nez-Arango JA, Zea-Vera AF, Gonz&#xe1;lez-Manrique G, Vargas J, et al. . Guillain-Barr&#xe9; syndrome associated with Zika virus infection in Colombia. New England J Med. (2016) 375:1513&#x2013;23. 10.1056/NEJMoa1605564</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1605564</ArticleId><ArticleId IdType="pubmed">27705091</ArticleId></ArticleIdList></Reference><Reference><Citation>Molko N, Simon O, Guyon D, Biron A, Dupont-Rouzeyrol M, Gourinat AC. Zika virus infection and myasthenia gravis: report of 2 cases. Neurology. (2017) 88:1097&#x2013;8. 10.1212/WNL.0000000000003697</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003697</ArticleId><ArticleId IdType="pubmed">28188305</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemignani F. Clinical spectrum of cryoglobulinaemic neuropathy. J Neurol, Neurosurg Psychiatry. (2005) 76:1410&#x2013;4. 10.1136/jnnp.2004.057620</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2004.057620</ArticleId><ArticleId IdType="pmc">PMC1739369</ArticleId><ArticleId IdType="pubmed">16170087</ArticleId></ArticleIdList></Reference><Reference><Citation>Charles ED, Dustin LB. Hepatitis C virus-induced cryoglobulinemia. Kidney Int. (2009) 76:818&#x2013;24. 10.1038/ki.2009.247</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2009.247</ArticleId><ArticleId IdType="pmc">PMC2755598</ArticleId><ArticleId IdType="pubmed">19606079</ArticleId></ArticleIdList></Reference><Reference><Citation>Rota E, Morelli N, Immovilli P, de Mitri P, Guidetti D. Guillain-Barr&#xe9;-like axonal polyneuropathy associated with Toscana virus infection. Medicine. (2017) 96:e8081. 10.1097/MD.0000000000008081</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000008081</ArticleId><ArticleId IdType="pmc">PMC5617714</ArticleId><ArticleId IdType="pubmed">28930847</ArticleId></ArticleIdList></Reference><Reference><Citation>Okar SV, Bekircan-Kurt CE, Hacioglu S, Erdem-&#xd6;zdamar S, &#xd6;zkul A, Erg&#xfc;nay K. Toscana virus associated with Guillain&#x2013;Barr&#xe9; syndrome: a case&#x2013;control study. Acta Neurol Belg. (2021) 121:661&#x2013;8. 10.1007/s13760-020-01279-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-020-01279-5</ArticleId><ArticleId IdType="pubmed">31970702</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CJ, Thomas RH, Pickersgill TP, Lyons M, Lowe G, Stiff RE, et al. . Cluster of atypical adult Guillain-Barr&#xe9; syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016. Eurosurveillance. (2016) 21:30119. 10.2807/1560-7917.ES.2016.21.4.30119</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.4.30119</ArticleId><ArticleId IdType="pubmed">26848143</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltadzhiev I, Geneva I, Popivanova N. Guillain-barr&#xe9; syndrome in a child with ongoing viral hepatitis a. Iranian J Child Neurol. (2018) 12:133&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6045941</ArticleId><ArticleId IdType="pubmed">30026778</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef GE, Isenberg DA, Mowbray JF. Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis. Ann Rheum Dis. (1990) 49:310&#x2013;5. 10.1136/ard.49.5.310</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.49.5.310</ArticleId><ArticleId IdType="pmc">PMC1004075</ArticleId><ArticleId IdType="pubmed">2160802</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Ma Y. Hepatitis E virus-associated Guillain&#x2013;Barre syndrome: Revision of the literature. Brain Behav. (2020) 10:e01496. 10.1002/brb3.1496</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1496</ArticleId><ArticleId IdType="pmc">PMC6955827</ArticleId><ArticleId IdType="pubmed">31828968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim JY, Lim YH, Choi EH. Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: a case report. Medicine (United States). (2016) 95:e5580. 10.1097/MD.0000000000005580</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000005580</ArticleId><ArticleId IdType="pmc">PMC5266044</ArticleId><ArticleId IdType="pubmed">27930572</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam B, Islam Z, Geurtsvankessel CH, Jahan I, Endtz HP, Mohammad QD, et al. . Guillain-Barr&#xe9; syndrome following varicella-zoster virus infection. Eur J Clin Microbiol Infect Dis. (2018) 37:511&#x2013;8. 10.1007/s10096-018-3199-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-018-3199-5</ArticleId><ArticleId IdType="pubmed">29411189</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;nemann JD, Tackenberg B, Stein A, Wandinger KP, Oertel WH, Wagner HJ, et al. . Dysregulated Epstein-Barr virus infection in patients with CIDP. J Neuroimmunol. (2010) 218:107&#x2013;11. 10.1016/j.jneuroim.2009.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.11.003</ArticleId><ArticleId IdType="pubmed">19939466</ArticleId></ArticleIdList></Reference><Reference><Citation>Communal C, Filleron A, Baron-Joly S, Salet R, Tran TA. Pediatric Miller Fisher Syndrome Complicating an Epstein&#x2013;Barr Virus Infection. Pediatr Neurol. (2016) 63:73&#x2013;5. 10.1016/j.pediatrneurol.2016.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2016.06.018</ArticleId><ArticleId IdType="pubmed">27460528</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafissi S, Vahabi Z, Ghahar MS, Amirzargar AA, Naderi S. The role of Cytomegalovirus, Haemophilus Influenzae and Epstein Barr Virus in Guillain Barre syndrome. Acta Med Iran. (2013) 51:372&#x2013;6. 10.1002/pmrj.12619</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12619</ArticleId><ArticleId IdType="pubmed">23852841</ArticleId></ArticleIdList></Reference><Reference><Citation>Faucard R, Madeira A, Gehin N, Authier FJ, Panaite PA, Lesage C, et al. . Human endogenous retrovirus and neuroinflammation in chronic inflammatory demyelinating polyradiculoneuropathy. EBioMedicine. (2016) 6:190&#x2013;8. 10.1016/j.ebiom.2016.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2016.03.001</ArticleId><ArticleId IdType="pmc">PMC4856744</ArticleId><ArticleId IdType="pubmed">27211560</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue YC, Feuer R, Cashman N, Luo H. Enteroviral infection: The forgotten link to amyotrophic lateral sclerosis? Front Mol Neurosci. (2018) 11:63. 10.3389/fnmol.2018.00063</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00063</ArticleId><ArticleId IdType="pmc">PMC5857577</ArticleId><ArticleId IdType="pubmed">29593492</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue YC, Ruller CM, Fung G, Mohamud Y, Deng H, Liu H, et al. . Enteroviral Infection Leads to Transactive Response DNA-Binding Protein 43 Pathology in Vivo. Am J Pathol. (2018) 188:2853&#x2013;62. 10.1016/j.ajpath.2018.08.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2018.08.013</ArticleId><ArticleId IdType="pubmed">30273599</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue YC, Liu H, Mohamud Y, Bahreyni A, Zhang J, Cashman NR, et al. . Sublethal enteroviral infection exacerbates disease progression in an ALS mouse model. J Neuroinflammation. (2022) 19:16. 10.1186/s12974-022-02380-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02380-7</ArticleId><ArticleId IdType="pmc">PMC8753920</ArticleId><ArticleId IdType="pubmed">35022041</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung G, Shi J, Deng H, Hou J, Wang C, Hong A, et al. . Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesis. Cell Death Differ. (2015) 22:2087&#x2013;97. 10.1038/cdd.2015.58</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.58</ArticleId><ArticleId IdType="pmc">PMC4816113</ArticleId><ArticleId IdType="pubmed">25976304</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanedo-Vazquez D, Bosque-Varela P, Sainz-Pelayo A, Riancho J. Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration. J Neurol. (2019) 266:27&#x2013;36. 10.1007/s00415-018-8919-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8919-3</ArticleId><ArticleId IdType="pubmed">29845377</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP. HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia. Acta Myol. (2011) 30:29&#x2013;31. Available online at: https://www.aafp.org/pubs/afp/issues/2003/0201/p519.html</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3185829</ArticleId><ArticleId IdType="pubmed">21842590</ArticleId></ArticleIdList></Reference><Reference><Citation>Satin ZA, Bayat E. ALS-Like Disorder in Three HIV-positive patients: case series. Case Rep Neurol. (2021). 13:59&#x2013;64. 10.1159/000511203</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511203</ArticleId><ArticleId IdType="pmc">PMC7923715</ArticleId><ArticleId IdType="pubmed">33708095</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras-Galindo R, L&#xf3;pez P, V&#xe9;lez R, Yamamura Y. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses. (2007) 23:116&#x2013;22. 10.1089/aid.2006.0117</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.2006.0117</ArticleId><ArticleId IdType="pubmed">17263641</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, van Damme P, et al. . Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases. Orphanet J Rare Dis. (2017) 12:86. 10.1186/s13023-017-0640-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-017-0640-2</ArticleId><ArticleId IdType="pmc">PMC5425967</ArticleId><ArticleId IdType="pubmed">28490364</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G, Cote HCF, Montaner JS Li CC, Jitratkosol M, Mezei MM. Ophthalmoplegia and ptosis. mitochondrial toxicity in patients receiving hiv therapy. Neurology. (2009) 73:71&#x2013;2. 10.1212/WNL.0b013e3181aae814</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181aae814</ArticleId><ArticleId IdType="pmc">PMC2830882</ArticleId><ArticleId IdType="pubmed">19564587</ArticleId></ArticleIdList></Reference><Reference><Citation>Couture P, Malfatti E, Morau G, Mathian A, Cohen-Aubart F, Nielly H, et al. . Inclusion body myositis and human immunodeficiency virus type 1: A new case report and literature review. Neuromusc Diso. (2018) 28:334&#x2013;8. 10.1016/j.nmd.2018.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2018.01.005</ArticleId><ArticleId IdType="pubmed">29426734</ArticleId></ArticleIdList></Reference><Reference><Citation>Westarp ME, Ferrante P, Perron H, Bartmann P, Kornhuber HH. Sporadic ALS/MND: a global neurodegeneration with retroviral involvement? J Neurol Sci. (1995) 129:145&#x2013;7. 10.1016/0022-510X(95)00087-I</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(95)00087-I</ArticleId><ArticleId IdType="pubmed">7595609</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Trujillo F, Parra Cortes K, &#xc1;lvarez Pareja Y, Onate J. Human T-cell lymphotropic virus type I associated with amyotrophic lateral sclerosis syndrome: immunopathological aspects and treatment options. Cureus. (2020) 12:e7531. 10.7759/cureus.7531</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.7531</ArticleId><ArticleId IdType="pmc">PMC7198105</ArticleId><ArticleId IdType="pubmed">32377479</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupler EJ, Leon-Monzon M, Miller J, Semino-Mora C, Anderson TL, Dalakas MC. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain. (1996) 119:1887&#x2013;93. 10.1093/brain/119.6.1887</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.6.1887</ArticleId><ArticleId IdType="pubmed">9009995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozden S, Gessain A, Gout O, Mikol J. Sporadic Inclusion Body Myositis in a Patient with Human T Cell Leukemia Virus Type 1-Associated Myelopathy. Clin Infect Dis. (2001) 32:510&#x2013;4. 10.1086/318506</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318506</ArticleId><ArticleId IdType="pubmed">11170963</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R, Liu J, Rothstein J, Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol. (2011) 69:141&#x2013;51. 10.1002/ana.22149</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22149</ArticleId><ArticleId IdType="pmc">PMC3052883</ArticleId><ArticleId IdType="pubmed">21280084</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, et al. . Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. (2015) 7:307ra153. 10.1126/scitranslmed.aac8201</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanmogne GD, Kennedy RC, Grammas P. HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia. J Neuropathol Exper Neurol. (2002) 61:992&#x2013;1000. 10.1093/jnen/61.11.992</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/61.11.992</ArticleId><ArticleId IdType="pubmed">12430716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer MF, Cook WJ, Roth FP, Zhu J, Holman H, Knipe DM, et al. . Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression. J Virol. (2003) 77:9533&#x2013;41. 10.1128/JVI.77.17.9533-9541.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.17.9533-9541.2003</ArticleId><ArticleId IdType="pmc">PMC187408</ArticleId><ArticleId IdType="pubmed">12915567</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. (2013) 13:379&#x2013;93. 10.1016/j.chom.2013.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.03.010</ArticleId><ArticleId IdType="pmc">PMC3647473</ArticleId><ArticleId IdType="pubmed">23601101</ArticleId></ArticleIdList></Reference><Reference><Citation>Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev. (2008) 21:473&#x2013;94. 10.1128/CMR.00001-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00001-08</ArticleId><ArticleId IdType="pmc">PMC2493084</ArticleId><ArticleId IdType="pubmed">18625683</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasca I, Damian L, Albu A. Infectious muscle disease. Rom J Intern Med. (2006) 44:131&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">17236294</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller FW, Lamb JA, Schmidt J, Nagaraju K. Risk factors and disease mechanisms in myositis. Nat. Rev. Rheumatol. (2018) 14:255&#x2013;68. 10.1038/nrrheum.2018.48</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2018.48</ArticleId><ArticleId IdType="pmc">PMC6745704</ArticleId><ArticleId IdType="pubmed">29674613</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman BP, Boon AJ. Critical Illness Neuromyopathy. Phys Med Rehabil Clin N Am. (2008) 19:97&#x2013;110. 10.1016/j.pmr.2007.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2007.10.012</ArticleId><ArticleId IdType="pubmed">18194752</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch CK, Hassan-Smith Z, A Greig C, M Lord J, A Jackson T. Acute sarcopenia secondary to hospitalisation - an emerging condition affecting older adults. Aging and Disease. (2018) 9:151&#x2013;64. 10.14336/AD.2017.0315</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2017.0315</ArticleId><ArticleId IdType="pmc">PMC5772853</ArticleId><ArticleId IdType="pubmed">29392090</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold R, Issar T, Krishnan A, Pussell BA. Neurological complications in chronic kidney disease. JRSM Cardiov Dis. (2016) 5:2048004016677687. 10.1177/2048004016677687</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048004016677687</ArticleId><ArticleId IdType="pmc">PMC5102165</ArticleId><ArticleId IdType="pubmed">27867500</ArticleId></ArticleIdList></Reference><Reference><Citation>McDougall AJ, Davies L, McCaughan GW. Autonomic and peripheral neuropathy in endstage liver disease and following liver transplantation. Muscle Nerve. (2003) 28:595&#x2013;600. 10.1002/mus.10477</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10477</ArticleId><ArticleId IdType="pubmed">14571462</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas M. Neurology of endocrine disease. Clin Med. (2010) 10:387&#x2013;90. 10.7861/clinmedicine.10-4-387</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.10-4-387</ArticleId><ArticleId IdType="pmc">PMC4952172</ArticleId><ArticleId IdType="pubmed">20849017</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti MK, Cyprian FS, Nasrallah GK, al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. (2019) 11:762. 10.3390/v11080762</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B, Kaistha SD, Rouse BT. Viruses and autoimmunity. Autoimmunity. (2006) 39:71&#x2013;7. 10.1080/08916930500484708</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500484708</ArticleId><ArticleId IdType="pubmed">16455584</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco Y, Acosta-Ampudia Y, Monsalve DM, Chang C, Gershwin ME, Anaya JM. Bystander activation and autoimmunity. J Autoimmun. (2019) 103:102301. 10.1016/j.jaut.2019.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.06.012</ArticleId><ArticleId IdType="pubmed">31326230</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesha SH, Durai M, Moudgil KD. Epitope spreading in autoimmune diseases. In: Infection and Autoimmunity. Baltimore, MD: Elsevier; (2015). p. 45&#x2013;68. 10.1016/B978-0-444-63269-2.00003-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63269-2.00003-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran AP, Annuk H, Prendergast MM. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. J Neuroimmunol. (2005) 165:179&#x2013;85. 10.1016/j.jneuroim.2005.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2005.04.013</ArticleId><ArticleId IdType="pubmed">15993494</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu RK, Usuki S, Ariga T. Ganglioside molecular mimicry and its pathological roles in guillain-barr&#xe9; syndrome and related diseases. Infect Immun. (2006) 74:6517&#x2013;27. 10.1128/IAI.00967-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00967-06</ArticleId><ArticleId IdType="pmc">PMC1698092</ArticleId><ArticleId IdType="pubmed">16966405</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki N, Tagawa Y, Handa S. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain&#x2013;Barr&#xe9; syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. (1996) 70:1&#x2013;6. 10.1016/S0165-5728(96)00042-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(96)00042-2</ArticleId><ArticleId IdType="pubmed">8862128</ArticleId></ArticleIdList></Reference><Reference><Citation>Walling A, Dickson G. Guillain-Barr&#xe9; syndrome. Am Fam Physician. (2013) 87:191&#x2013;7. 10.1186/s12883-022-02622-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02622-4</ArticleId><ArticleId IdType="pubmed">23418763</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Longo MR. Guillain&#x2013;Barr&#xe9; syndrome. Autoimmun Rev. (2017) 16:96&#x2013;101. 10.1016/j.autrev.2016.09.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2016.09.022</ArticleId><ArticleId IdType="pubmed">27666816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N. Conduction block in acute motor axonal neuropathy. Brain. (2010) 133:2897&#x2013;908. 10.1093/brain/awq260</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq260</ArticleId><ArticleId IdType="pubmed">20855419</ArticleId></ArticleIdList></Reference><Reference><Citation>Peediackal S, Jose J, Gafoor VA, Smitha B. Reversible conduction failure in acute motor axonal neuropathy. Ann Indian Acad Neurol. (2014) 17:142&#x2013;3. 10.4103/0972-2327.128601</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-2327.128601</ArticleId><ArticleId IdType="pmc">PMC3992763</ArticleId><ArticleId IdType="pubmed">24753690</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg JH, Radecki J. Parsonage-turner syndrome. HSS J. (2010) 6:199&#x2013;205. 10.1007/s11420-010-9176-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11420-010-9176-x</ArticleId><ArticleId IdType="pmc">PMC2926354</ArticleId><ArticleId IdType="pubmed">21886536</ArticleId></ArticleIdList></Reference><Reference><Citation>Magee H, Goldman RD. Viral myositis in children. Can Fam Physician. (2017) 63:365&#x2013;8. Available online at: https://acta.tums.ac.ir/index.php/acta/article/view/4428</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5429052</ArticleId><ArticleId IdType="pubmed">28500193</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. . Amyotrophic lateral sclerosis. Nat Rev Dis Primers. (2017) 3:17071. 10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. (2015) 7:181&#x2013;93. 10.2147/CLEP.S37505</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, et al. . Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. (2014) 13:1108&#x2013;13. 10.1016/S1474-4422(14)70219-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala-Nunez NV, Gaudin R. A viral journey to the brain: current considerations and future developments. Evans MJ, editor PLOS Pathogens. (2020) 16:e1008434. 10.1371/journal.ppat.1008434</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008434</ArticleId><ArticleId IdType="pmc">PMC7241694</ArticleId><ArticleId IdType="pubmed">32437459</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, G&#xe1;lvez NMS, R&#xed;os M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. (2018) 12:386. 10.3389/fncel.2018.00386</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00386</ArticleId><ArticleId IdType="pmc">PMC6212673</ArticleId><ArticleId IdType="pubmed">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley CA. Emergent Viral Infections of the CNS. J Neuropathol Exper Neurol. (2020) 79:823&#x2013;42. 10.1093/jnen/nlaa054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlaa054</ArticleId><ArticleId IdType="pubmed">32647884</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson AM, Wysocki J, Batlle D. Interaction of SARS-CoV-2 and other coronavirus with ACE (Angiotensin-Converting Enzyme)-2 as their main receptor. Hypertension. (2020) 76:1339&#x2013;49. 10.1161/HYPERTENSIONAHA.120.15256</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15256</ArticleId><ArticleId IdType="pmc">PMC7480804</ArticleId><ArticleId IdType="pubmed">32851855</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, Lipovsek M, van den Berge K, Gong B, et al. . Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. (2020) 6:eabc5801. 10.1126/sciadv.abc5801</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. (2021) 24:168&#x2013;75. 10.1101/2020.06.04.135012</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.04.135012</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in COVID-19: a systematic review. Wellcome Open Res. (2020) 5:94. 10.12688/wellcomeopenres.15917.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.15917.1</ArticleId><ArticleId IdType="pmc">PMC7308993</ArticleId><ArticleId IdType="pubmed">32587902</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R, von Bartheld CS. Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection. Neuroscientist. (2021) 27:582&#x2013;603. 10.1177/1073858420956905</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420956905</ArticleId><ArticleId IdType="pmc">PMC7488171</ArticleId><ArticleId IdType="pubmed">32914699</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitscheider L, Karolyi M, Burkert FR, Helbok R, Wanschitz J, Horlings C, et al. . Muscle involvement in SARS-CoV-2 infection. Eur J Neurol. (2020) 28:3411&#x2013;7. 10.1111/ene.14564</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14564</ArticleId><ArticleId IdType="pmc">PMC7537196</ArticleId><ArticleId IdType="pubmed">32997370</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B, Kaur P, Mechineni A, Maroules M. Rhabdomyolysis in COVID-19: report of four cases. Cureus. (2020) 12:e10686. 10.7759/cureus.10686</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10686</ArticleId><ArticleId IdType="pmc">PMC7523746</ArticleId><ArticleId IdType="pubmed">33005556</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel HH, et al. . Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. (2021) 78:948. 10.1001/jamaneurol.2021.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2004</ArticleId><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and myositis: what we know so far. Curr Rheumatol Rep. (2021) 23:63. 10.1007/s11926-021-01023-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-021-01023-9</ArticleId><ArticleId IdType="pmc">PMC8254439</ArticleId><ArticleId IdType="pubmed">34216297</ArticleId></ArticleIdList></Reference><Reference><Citation>Meegada S, Muppidi V, Wilkinson DC, Siddamreddy S, Katta SK. Coronavirus disease 2019-induced rhabdomyolysis. Cureus. (2020) 12:e10123. 10.7759/cureus.10123</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10123</ArticleId><ArticleId IdType="pmc">PMC7456629</ArticleId><ArticleId IdType="pubmed">32879836</ArticleId></ArticleIdList></Reference><Reference><Citation>Chedid NR, Udit S, Solhjou Z, Patanwala MY, Sheridan AM, Barkoudah E. COVID-19 and rhabdomyolysis. J Gen Intern Med. (2020) 35:3087&#x2013;90. 10.1007/s11606-020-06039-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06039-y</ArticleId><ArticleId IdType="pmc">PMC7363012</ArticleId><ArticleId IdType="pubmed">32671722</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. (2021) 384:693&#x2013;704. 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Li Z, Jiang L, Xi X. Corticosteroid use and intensive care unit-acquired weakness: a systematic review and meta-analysis. Crit Care. (2018) 22:187. 10.1186/s13054-018-2111-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2111-0</ArticleId><ArticleId IdType="pmc">PMC6091087</ArticleId><ArticleId IdType="pubmed">30075789</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermans G, de Jonghe B, Bruyninckx F, van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Datab System Rev. (2014) 2014:CD006832. 10.1002/14651858.CD006832.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006832.pub3</ArticleId><ArticleId IdType="pmc">PMC7390458</ArticleId><ArticleId IdType="pubmed">24477672</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz de Jardim, Mello L, Guimaraes Silva E, Oliveira Correa Rabelo G, Evaristo Leite M, Vieira NR, Bahadori M, et al. . Neurologic compromise in COVID-19: a literature review. J Neurol Res. (2020) 10:164&#x2013;72. 10.14740/jnr619</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jnr619</ArticleId><ArticleId IdType="pmc">PMC8040461</ArticleId><ArticleId IdType="pubmed">33984100</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. (2020). 10.1101/2020.01.26.919985</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.01.26.919985</ArticleId><ArticleId IdType="pmc">PMC7462411</ArticleId><ArticleId IdType="pubmed">32663409</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain&#x2013;Barr&#xe9; syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. (2021) 268:1133&#x2013;70. 10.1007/s00415-020-10124-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10124-x</ArticleId><ArticleId IdType="pmc">PMC7445716</ArticleId><ArticleId IdType="pubmed">32840686</ArticleId></ArticleIdList></Reference><Reference><Citation>d'Orsi G, Sica S, Maiorano A, Melchionda D, Lalla A, Montemurro L, et al. . Guillain-Barr&#xe9; syndrome as only manifestation of COVID-19 infection. Clin Neurol Neurosur. (2021) 207:106775. 10.1016/j.clineuro.2021.106775</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2021.106775</ArticleId><ArticleId IdType="pmc">PMC8222978</ArticleId><ArticleId IdType="pubmed">34175645</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JL, Ebadi H, Sarna JR. Guillain-Barr&#xe9; syndrome with facial diplegia related to SARS-CoV-2 infection. Canadian J Neurol Sci. (2020) 47:852&#x2013;4. 10.1017/cjn.2020.106</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.106</ArticleId><ArticleId IdType="pmc">PMC7308598</ArticleId><ArticleId IdType="pubmed">32468972</ArticleId></ArticleIdList></Reference><Reference><Citation>Juliao Caama&#xf1;o DS, Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain-Barr&#xe9; Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. (2020) 77:230&#x2013;2. 10.1016/j.jocn.2020.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.05.016</ArticleId><ArticleId IdType="pmc">PMC7221378</ArticleId><ArticleId IdType="pubmed">32410788</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchins KL, Jansen JH, Comer AD, Scheer RV, Zahn GS, Capps AE, et al. . COVID-19&#x2013;Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barr&#xe9; Syndrome. Am J Neuroradiol. (2020) 41:1707&#x2013;11. 10.3174/ajnr.A6654</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6654</ArticleId><ArticleId IdType="pmc">PMC7583115</ArticleId><ArticleId IdType="pubmed">32586958</ArticleId></ArticleIdList></Reference><Reference><Citation>Keddie S, Pakpoor J, Mousele C, Pipis M, Machado PM, Foster M, et al. . Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr&#xe9; syndrome. Brain. (2021) 144:682&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799186</ArticleId><ArticleId IdType="pubmed">33313649</ArticleId></ArticleIdList></Reference><Reference><Citation>Foschi M, D'Anna L, Abdelhak A, Mayer B, Tumani H, Otto M, et al. . Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barr&#xe9; syndrome. Brain. (2021) 144:e44&#x2013;e44. 10.1093/brain/awab069</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab069</ArticleId><ArticleId IdType="pmc">PMC8083498</ArticleId><ArticleId IdType="pubmed">33822000</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik GR, Wolfe AR, Soriano R, Rydberg L, Wolfe LF, Deshmukh S, et al. . Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome. Br J Anaesth. (2020) 125:e478&#x2013;80. 10.1016/j.bja.2020.08.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.08.045</ArticleId><ArticleId IdType="pmc">PMC7473147</ArticleId><ArticleId IdType="pubmed">32948295</ArticleId></ArticleIdList></Reference><Reference><Citation>Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, et al. . Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations. Cytokine. (2021) 138:155404. 10.1016/j.cyto.2020.155404</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155404</ArticleId><ArticleId IdType="pmc">PMC7832981</ArticleId><ArticleId IdType="pubmed">33360025</ArticleId></ArticleIdList></Reference><Reference><Citation>Enrique ER, Javier BH, Hernando R, Herney Andr&#xe9;s GP. Mononeuritis Multiplex Associated with Sars-Cov2-Covid-19 Infection: Case Report. Int J Neurol Neurotherapy. (2020) 7:102. 10.23937/2378-3001/1410102</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/2378-3001/1410102</ArticleId></ArticleIdList></Reference><Reference><Citation>Assar S, Pournazari M, Soufivand P, Mohamadzadeh D, Sanaee S. Microscopic polyangiitis associated with coronavirus disease-2019 (COVID-19) infection in an elderly male. Egyptian Rheumatol. (2021) 43:225&#x2013;8. 10.1016/j.ejr.2021.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejr.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC7942159</ArticleId><ArticleId IdType="pubmed">38620809</ArticleId></ArticleIdList></Reference><Reference><Citation>Coll C, Tessier M, Vandendries C, Seror P. Neuralgic amyotrophy and COVID-19 infection: 2 cases of spinal accessory nerve palsy. Joint Bone Spine. (2021) 88:105196. 10.1016/j.jbspin.2021.105196</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2021.105196</ArticleId><ArticleId IdType="pmc">PMC8064823</ArticleId><ArticleId IdType="pubmed">33901661</ArticleId></ArticleIdList></Reference><Reference><Citation>Viatg&#xe9; T, Noel-Savina E, Pr&#xe9;vot G, Faviez G, Plat G, de Boissezon X, et al. . [Parsonage-Turner syndrome following severe SARS-CoV-2 infection]. Rev Mal Respir. (2021) 38:853&#x2013;8. 10.1016/j.rmr.2021.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmr.2021.06.004</ArticleId><ArticleId IdType="pmc">PMC8233958</ArticleId><ArticleId IdType="pubmed">34325956</ArticleId></ArticleIdList></Reference><Reference><Citation>Manji H, Carr AS, Brownlee WJ, Lunn MP. Neurology in the time of COVID-19. J Neurol Neurosurg Psychiatry. (2020) 91:568&#x2013;70. 10.1136/jnnp-2020-323414</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323414</ArticleId><ArticleId IdType="pubmed">32312872</ArticleId></ArticleIdList></Reference><Reference><Citation>Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia Gravis Associated With SARS-CoV-2 Infection. Ann Intern Med. (2020) 173:1027&#x2013;8. 10.7326/L20-0845</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-0845</ArticleId><ArticleId IdType="pmc">PMC7429993</ArticleId><ArticleId IdType="pubmed">32776781</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, et al. . Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID. Neurol Neuroimmunol Neuroinflam. (2022) 9:e1146. 10.1212/NXI.0000000000001146</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. (2022) 65:440&#x2013;3. 10.1002/mus.27458</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard J, Leth S, Pedersen TH, Harbo T, Blicher JU, Karlsson P, et al. . Myopathic changes in patients with long-term fatigue after COVID-19. Clin Neurophysiol. (2021) 132:1974&#x2013;81. 10.1016/j.clinph.2021.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.04.009</ArticleId><ArticleId IdType="pmc">PMC8102077</ArticleId><ArticleId IdType="pubmed">34020890</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, et al. . Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. (2021) 31:385&#x2013;94. 10.1007/s10286-021-00803-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadda KR, Blakey EE, Huang CLH, Jeevaratnam K. Long COVID-19 and postural orthostatic tachycardia syndrome- is dysautonomia to be blamed? Front Cardiovasc Med. (2022) 9:860198. 10.3389/fcvm.2022.860198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.860198</ArticleId><ArticleId IdType="pmc">PMC8959615</ArticleId><ArticleId IdType="pubmed">35355961</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. (2022) 185:881&#x2013;895.e20. 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G, Povitz M. Respiratory management of patients with neuromuscular disease: current perspectives. Degener Neurol Neuromuscul Dis. (2016) 6:111&#x2013;8. 10.2147/DNND.S87323</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DNND.S87323</ArticleId><ArticleId IdType="pmc">PMC6053085</ArticleId><ArticleId IdType="pubmed">30050373</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuper H, Banks LM, Bright T, Davey C, Shakespeare T. Disability-inclusive COVID-19 response: What it is, why it is important and what we can learn from the United Kingdom's response. Wellcome Open Res. (2020) 5:79. 10.12688/wellcomeopenres.15833.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.15833.1</ArticleId><ArticleId IdType="pmc">PMC7236579</ArticleId><ArticleId IdType="pubmed">32500099</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Garc&#xed;a I, Perales-Fraile I, Gonz&#xe1;lez-Garc&#xed;a A, Mu&#xf1;oz-Blanco A, Manzano L, Fabregate M, et al. . In-hospital mortality among immunosuppressed patients with COVID-19: analysis from a national cohort in Spain. PLoS ONE. (2021) 16:e0255524. 10.1371/journal.pone.0255524</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255524</ArticleId><ArticleId IdType="pmc">PMC8330927</ArticleId><ArticleId IdType="pubmed">34343222</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaradeh S. Muscle Disorders Affecting Oral and Pharyngeal Swallowing. GI Motility online. (2006).</Citation></Reference><Reference><Citation>Phelps M, Christensen DM, Gerds T, Fosb&#xf8;l E, Torp-Pedersen C, Schou M, et al. . Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. Eur Heart J. (2021) 7:172&#x2013;80. 10.1093/ehjqcco/qcaa081</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcaa081</ArticleId><ArticleId IdType="pmc">PMC7665490</ArticleId><ArticleId IdType="pubmed">33107909</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurologists A of B . Association of British Neurologists Guidance on COVID-19 for people with neurological conditions, their doctors and carers. (2020). Available online at: https://cdn.ymaws.com/www.theabn.org/resource/collection/65C334C7-30FA-45DB-93AA-74B3A3A20293/ABN_Neurology_COVID-19_Guidance_v5_26.3.20.pdf (accessed June 15, 2021).</Citation></Reference><Reference><Citation>Pfeffer G, Jacob S, Preston J. COVID-19 vaccine priority for people with neurologic and rare diseases. J Neurol Res. (2021) 11:1&#x2013;4. 10.14740/jnr665</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jnr665</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Iezzoni LI, Rao SR, Ressalam J, Bolcic-Jankovic D, Agaronnik ND, Donelan K, et al. . Physicians' perceptions of people with disability and their health care. Health Aff. (2021) 40:297&#x2013;306. 10.1377/hlthaff.2020.01452</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2020.01452</ArticleId><ArticleId IdType="pmc">PMC8722582</ArticleId><ArticleId IdType="pubmed">33523739</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson C. Ontario patients to be ranked for life-saving care should ICUs become full, documents show. (2021). Available online at: https://toronto.ctvnews.ca/ontario-patients-to-be-ranked-for-life-saving-care-should-icus-become-full-documents-show-1.5271774 (accessed June 15, 2021).</Citation></Reference><Reference><Citation>Armitage R, Nellums LB. The COVID-19 response must be disability inclusive. Lancet Public Health. (2020) 5:e257. 10.1016/S2468-2667(20)30076-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30076-1</ArticleId><ArticleId IdType="pmc">PMC7270835</ArticleId><ArticleId IdType="pubmed">32224295</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleman J, Kruitwagen ET, van den Berg LH, Visser-Meily JMA, Beelen A. The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review. Amyotrophic Lateral Sclerosis Frontotemporal Degeneration. (2020) 21:167&#x2013;82. 10.1080/21678421.2019.1706581</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1706581</ArticleId><ArticleId IdType="pubmed">31878794</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellenberg KL, Hansen G. Patient perspectives on transitioning to amyotrophic lateral sclerosis multidisciplinary clinics. J Multidiscip Healthc. (2018) 11:519&#x2013;24. 10.2147/JMDH.S177563</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S177563</ArticleId><ArticleId IdType="pmc">PMC6171753</ArticleId><ArticleId IdType="pubmed">30319269</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoesmith C, Abrahao A, Benstead T, Chum M, Dupre N, Izenberg A, et al. . Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. Can Med Assoc J. (2020) 192:E1453&#x2013;68. 10.1503/cmaj.191721</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.191721</ArticleId><ArticleId IdType="pmc">PMC7683000</ArticleId><ArticleId IdType="pubmed">33199452</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R, Moglia C, D'Ovidio F, di Pede F, de Mattei F, Cabras S, et al. . Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotroph Lateral Scler Frontotemporal Degener. (2021) 22:308&#x2013;11. 10.1080/21678421.2020.1820043</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1820043</ArticleId><ArticleId IdType="pubmed">32924624</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Rumeileh S, Garibashvili T, Ruf W, Fangerau T, Kassubek J, Althaus K, et al. . Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19. J Neurol Sci. (2020) 418:117106. 10.1016/j.jns.2020.117106</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117106</ArticleId><ArticleId IdType="pmc">PMC7462872</ArticleId><ArticleId IdType="pubmed">32911389</ArticleId></ArticleIdList></Reference><Reference><Citation>van Looy E, Veenker L, Steyaert A, Leenders J, Malfroid G, de Cauwer H. COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy. J Neurol. (2021) 268:3129&#x2013;31. 10.1007/s00415-021-10417-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10417-9</ArticleId><ArticleId IdType="pmc">PMC7892325</ArticleId><ArticleId IdType="pubmed">33606069</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen KM, Mehta HB, Palamuttam N, Ford D, Garibaldi BT, Auwaerter PG, et al. . Association between chronic use of immunosuppresive drugs and clinical outcomes from coronavirus disease 2019 (COVID-19) hospitalization: a retrospective cohort study in a large US health system. Clin Infect Dis. (2021) 73:e4124&#x2013;30. 10.1093/cid/ciaa1488</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1488</ArticleId><ArticleId IdType="pmc">PMC7953980</ArticleId><ArticleId IdType="pubmed">33410884</ArticleId></ArticleIdList></Reference><Reference><Citation>Muppidi S, Guptill JT, Jacob S, Li Y, Farrugia ME, Guidon AC, et al. . COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol. (2020) 19:970&#x2013;1. 10.1016/S1474-4422(20)30413-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30413-0</ArticleId><ArticleId IdType="pmc">PMC7837033</ArticleId><ArticleId IdType="pubmed">33212055</ArticleId></ArticleIdList></Reference><Reference><Citation>Squire J, Joshi A. Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency. Ann Allergy Asthma Immunol. (2021) 127:383&#x2013;4. 10.1016/j.anai.2021.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2021.05.015</ArticleId><ArticleId IdType="pmc">PMC8132495</ArticleId><ArticleId IdType="pubmed">34022388</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel J, Czitrom SG, Mallick A, Sellam J, Sibilia J. Vaccinations in adults with chronic inflammatory joint disease: Immunization schedule and recommendations for patients taking synthetic or biological disease-modifying antirheumatic drugs. Joint Bone Spine. (2016) 83:135&#x2013;41. 10.1016/j.jbspin.2015.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2015.08.008</ArticleId><ArticleId IdType="pubmed">26453106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahil SK, Bechman K, Raharja A, Domingo-Vila C, Baudry D, Brown MA, et al. . The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study. Lancet Rheumatol. (2021) 3:e627&#x2013;37. 10.1016/S2665-9913(21)00212-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00212-5</ArticleId><ArticleId IdType="pmc">PMC8266273</ArticleId><ArticleId IdType="pubmed">34258590</ArticleId></ArticleIdList></Reference><Reference><Citation>Caillard S, Chavarot N, Bertrand D, Kamar N, Thaunat O, Moal V, et al. . Occurrence of severe COVID-19 in vaccinated transplant patients. Kidney Int. (2021) 100:477&#x2013;9. 10.1016/j.kint.2021.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.05.011</ArticleId><ArticleId IdType="pmc">PMC8141267</ArticleId><ArticleId IdType="pubmed">34029554</ArticleId></ArticleIdList></Reference><Reference><Citation>Grave C, Boucheron P, Rudant J, Mikaeloff Y, Tubert-Bitter P, Escolano S, et al. . Seasonal influenza vaccine and Guillain-Barr&#xe9; syndrome. Neurology. (2020) 94:e2168&#x2013;79. 10.1212/WNL.0000000000009180</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009180</ArticleId><ArticleId IdType="pubmed">32098853</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe1;rquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain-Barr&#xe9; syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial. Neurology. (2021) 96:1052&#x2013;4. 10.1212/WNL.0000000000011881</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011881</ArticleId><ArticleId IdType="pubmed">33824169</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Exacerbating Guillain&#x2013;Barr&#xe9; syndrome eight days after vector-based COVID-19 vaccination. Case Rep Infect Dis. (2021) 2021:3619131. 10.1155/2021/3619131</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/3619131</ArticleId><ArticleId IdType="pmc">PMC8123983</ArticleId><ArticleId IdType="pubmed">34055430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogbebor O, Seth H, Min Z, Bhanot N. Guillain-Barr&#xe9; syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases. (2021) 24:e01143. 10.1016/j.idcr.2021.e01143</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2021.e01143</ArticleId><ArticleId IdType="pmc">PMC8086372</ArticleId><ArticleId IdType="pubmed">33968610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling L, Bagshaw SM, Villeneuve PM. Guillain&#x2013;Barr&#xe9; syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain&#x2013;Barr&#xe9; syndrome. Can Med Assoc J. (2021) 193:E1766&#x2013;9. 10.1503/cmaj.210947</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.210947</ArticleId><ArticleId IdType="pmc">PMC8608454</ArticleId><ArticleId IdType="pubmed">34810163</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro Ben David S, Potasman I, Rahamim-Cohen D. Rate of Recurrent Guillain-Barr&#xe9; Syndrome After mRNA COVID-19 Vaccine BNT162b2. JAMA Neurol. (2021) 78:1409. 10.1001/jamaneurol.2021.3287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.3287</ArticleId><ArticleId IdType="pmc">PMC8411356</ArticleId><ArticleId IdType="pubmed">34468703</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun JY, Park S, Jung J, Kim SH, Kim TS, Choi YJ, et al. . Guillain-Barr&#xe9; syndrome after vaccination against COVID-19. Lancet Neurol. (2022) 21:117&#x2013;9. 10.1016/S1474-4422(21)00416-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00416-6</ArticleId><ArticleId IdType="pmc">PMC8683117</ArticleId><ArticleId IdType="pubmed">34929194</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 Subcommittee on Reports of Guillain-Barr&#xe9; Syndrome (GBS) Following Adenovirus Vector COVID-19 Vaccines. Geneva: WHO; (2021). p. 26&#x2013;8.</Citation></Reference><Reference><Citation>de Souza A, Oo WM, Giri P. Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course. J Neurol Sci. (2022) 436:120231. 10.1016/j.jns.2022.120231</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120231</ArticleId><ArticleId IdType="pmc">PMC8923716</ArticleId><ArticleId IdType="pubmed">35313224</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagella CF, Corda DG, Zara P, Elia AE, Ruiu E, Sechi E, et al. . Chronic Inflammatory Demyelinating Polyneuropathy after ChAdOx1 nCoV-19 Vaccination. Vaccines (Basel). (2021) 9:1502. 10.3390/vaccines9121502</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9121502</ArticleId><ArticleId IdType="pmc">PMC8706382</ArticleId><ArticleId IdType="pubmed">34960248</ArticleId></ArticleIdList></Reference><Reference><Citation>Suri V, Pandey S, Singh J, Jena A. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination. BMJ Case Rep. (2021) 14:e245816. 10.1136/bcr-2021-245816</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-245816</ArticleId><ArticleId IdType="pmc">PMC8491284</ArticleId><ArticleId IdType="pubmed">34607818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Gupta A. A Rare case of brachial plexus neuropraxia after COVID-19 vaccination. Cureus. (2022) 14:e21244. 10.7759/cureus.21244</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.21244</ArticleId><ArticleId IdType="pmc">PMC8844251</ArticleId><ArticleId IdType="pubmed">35186534</ArticleId></ArticleIdList></Reference><Reference><Citation>Queler SC, Towbin AJ, Milani C, Whang J, Sneag DB. Parsonage-turner syndrome following COVID-19 vaccination: MR neurography. Radiology. (2022) 302:84&#x2013;7. 10.1148/radiol.2021211374</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211374</ArticleId><ArticleId IdType="pmc">PMC8488809</ArticleId><ArticleId IdType="pubmed">34402669</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Segarra N, Edmond A, Gilbert C, Mckay O, Kloepping C, Yonclas P. Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: A case report. PM&amp;R. (2021). Available online at: https://www.aafp.org/pubs/afp/issues/2013/0201/p191.html?utm_medium=email&amp;utm_source=transaction. [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250535</ArticleId><ArticleId IdType="pubmed">33886164</ArticleId></ArticleIdList></Reference><Reference><Citation>Shields LBE, Iyer VG, Zhang YP, Burger JT, Shields CB. Parsonage-turner syndrome following COVID-19 vaccination: clinical and electromyographic findings in 6 patients. Case Rep Neurol. (2022) 14:58&#x2013;67. 10.1159/000521462</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000521462</ArticleId><ArticleId IdType="pmc">PMC8921964</ArticleId><ArticleId IdType="pubmed">35350287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vutipongsatorn K, Isaacs A, Farah Z. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports. J Med Case Rep. (2022) 16:57. 10.1186/s13256-022-03266-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-022-03266-1</ArticleId><ArticleId IdType="pmc">PMC8801240</ArticleId><ArticleId IdType="pubmed">35094715</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N. COVID-19 vaccine-related myositis. QJM Int J Med. (2021) 114:424&#x2013;5. 10.1093/qjmed/hcab043</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab043</ArticleId><ArticleId IdType="pmc">PMC7989152</ArticleId><ArticleId IdType="pubmed">33647971</ArticleId></ArticleIdList></Reference><Reference><Citation>Psichogiou M, Samarkos M, Mikos N, Hatzakis A. Reactivation of varicella zoster virus after vaccination for SARS-CoV-2. Vaccines (Basel). (2021) 9:572. 10.3390/vaccines9060572</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9060572</ArticleId><ArticleId IdType="pmc">PMC8228758</ArticleId><ArticleId IdType="pubmed">34205861</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez-Domingo J, Parikh R, Bhavsar AB, Cisneros E, McCormick N, Lecrenier N. Can COVID-19 increase the risk of herpes zoster? A Narrative Review. Dermatol Ther (Heidelb). (2021) 11:1119&#x2013;26. 10.1007/s13555-021-00549-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13555-021-00549-1</ArticleId><ArticleId IdType="pmc">PMC8126597</ArticleId><ArticleId IdType="pubmed">33999370</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Restrepo-Jim&#xe9;nez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ram&#xed;rez-Santana C, et al. . Molecular mimicry and autoimmunity. J Autoimmun. (2018) 95:100&#x2013;23. 10.1016/j.jaut.2018.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.012</ArticleId><ArticleId IdType="pubmed">30509385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafeiriou D, Katzos G, Gombakis N, Kontopoulos E, Tsantali C. Clinical features, laboratory findings and differential diagnosis of benign acute childhood myositis. Acta Paediatr. (2000) 89:1493&#x2013;4. 10.1111/j.1651-2227.2000.tb02783.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2000.tb02783.x</ArticleId><ArticleId IdType="pubmed">11195243</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis LE, Kornfeld M. Experimental influenza B viral myositis. J Neurol Sci. (2001) 187:61&#x2013;7. 10.1016/S0022-510X(01)00526-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00526-3</ArticleId><ArticleId IdType="pubmed">11440746</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis LE. Neurologic and Muscular Complications of the 2009 Influenza A (H1N1) Pandemic. Curr Neurol Neurosci Rep. (2010) 10:476&#x2013;83. 10.1007/s11910-010-0135-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-010-0135-1</ArticleId><ArticleId IdType="pubmed">20697982</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi SL, Ross TM, Evans JD. West Nile Virus. Clin Lab Med. (2010) 30:47&#x2013;65. 10.1016/j.cll.2009.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cll.2009.10.006</ArticleId><ArticleId IdType="pmc">PMC2905782</ArticleId><ArticleId IdType="pubmed">20513541</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao-Lormeau VM, Blake A, Mons S, Last&#xe8;re S, Roche C, Vanhomwegen J, et al. . Guillain-Barr&#xe9; Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. (2016) 387:1531&#x2013;9. 10.1016/S0140-6736(16)00562-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00562-6</ArticleId><ArticleId IdType="pmc">PMC5444521</ArticleId><ArticleId IdType="pubmed">26948433</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelo JR, Fuller TL, Leandro BBS, Pra&#xe7;a HLF, Marques RD, Ferreira JMC, et al. . Neurological complications associated with emerging viruses in Brazil. Int J Gynecol Obstetrics. (2020) 148:70&#x2013;5. 10.1002/ijgo.13050</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.13050</ArticleId><ArticleId IdType="pmc">PMC7065065</ArticleId><ArticleId IdType="pubmed">31975402</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatun M, Ray RB. Mechanisms underlying hepatitis C virus-associated hepatic fibrosis. Cells. (2019) 8:1249. 10.3390/cells8101249</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101249</ArticleId><ArticleId IdType="pmc">PMC6829586</ArticleId><ArticleId IdType="pubmed">31615075</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D. Cryoglobulinemia Vasculitis. Am J Med. (2015) 128:950&#x2013;5. 10.1016/j.amjmed.2015.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2015.02.017</ArticleId><ArticleId IdType="pubmed">25837517</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman L, Dhamne M, Li Y. Neurologic manifestations associated with cryoglobulinemia: A single center experience. J Neurol Sci. (2019) 398:121&#x2013;7. 10.1016/j.jns.2019.01.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.01.041</ArticleId><ArticleId IdType="pubmed">30708209</ArticleId></ArticleIdList></Reference><Reference><Citation>Charrel RN. Emergence of Toscana virus in the mediterranean area. World J Virology. (2012) 1:135&#x2013;41. 10.5501/wjv.v1.i5.135</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v1.i5.135</ArticleId><ArticleId IdType="pmc">PMC3782275</ArticleId><ArticleId IdType="pubmed">24175218</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Abzug MJ, Dominguez SR. 2014 outbreak of enterovirus D68 in North America. J Med Virol. (2016) 88:739&#x2013;45. 10.1002/jmv.24410</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24410</ArticleId><ArticleId IdType="pubmed">26489019</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger AL, Naccache SN, Messacar K, Clayton A, Yu G, Somasekar S, et al. . A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study. Lancet Infect Dis. (2015) 15:671&#x2013;82. 10.1016/S1473-3099(15)70093-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)70093-9</ArticleId><ArticleId IdType="pmc">PMC6027625</ArticleId><ArticleId IdType="pubmed">25837569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. (2010) 9:1097&#x2013;105. 10.1016/S1474-4422(10)70209-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>MORI M, TAKAGI K, KUWABARA S, HATTORI T, KOJIMA S. Guillain-Barre Syndrome Following Hand-foot-and-mouth Disease. Internal Med. (2000) 39:503&#x2013;5. 10.2169/internalmedicine.39.503</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.39.503</ArticleId><ArticleId IdType="pubmed">10852174</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. (2001) 32:236&#x2013;42. 10.1086/318454</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Jehn UW, Fink MK. Myositis, myoglobinemia, and myoglobinuria associated with enterovirus echo 9 infection. Arch Neurol. (1980) 37:457&#x2013;8. 10.1001/archneur.1980.00500560087016</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1980.00500560087016</ArticleId><ArticleId IdType="pubmed">7387495</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrey J, Wang H, Hurst B, Zukor K, Siddharthan V, van Wettere A, et al. . Causation of acute flaccid paralysis by myelitis and myositis in enterovirus-D68 infected mice deficient in interferon &#x3b1;&#x3b2;/&#x3b3; receptor deficient mice. Viruses. (2018) 10:33. 10.3390/v10010033</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10010033</ArticleId><ArticleId IdType="pmc">PMC5795446</ArticleId><ArticleId IdType="pubmed">29329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jongen PJ, Zoll GJ, Beaumont M, Melchers WJ, van de Putte LB, Galama JM. Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle. Ann Rheum Dis. (1993) 52:575&#x2013;8. 10.1136/ard.52.8.575</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.52.8.575</ArticleId><ArticleId IdType="pmc">PMC1005113</ArticleId><ArticleId IdType="pubmed">8215618</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Gillen AP, et al. . Guillain-Barr&#xe9; syndrome associated with preceding hepatitis E virus infection. Neurology. (2014) 82:491&#x2013;7. 10.1212/WNL.0000000000000111</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000111</ArticleId><ArticleId IdType="pubmed">24415572</ArticleId></ArticleIdList></Reference><Reference><Citation>Geurtsvankessel CH, Islam Z, Mohammad QD, Jacobs BC, Endtz HP, Osterhaus ADME. Hepatitis E and Guillain-Barre syndrome. Clin Infect Dis. (2013) 57:1369&#x2013;70. 10.1093/cid/cit512</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cit512</ArticleId><ArticleId IdType="pubmed">23899686</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila JD, Lacomis D, Lam EM. Neuralgic amyotrophy associated with hepatitis E virus infection: first case in the United States. J Clin Neuromuscul Dis. (2016) 18:96&#x2013;100. 10.1097/CND.0000000000000137</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CND.0000000000000137</ArticleId><ArticleId IdType="pubmed">27861224</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisciglia M, van den Bergh P, Duprez T, Kabamba BM, Ivanoiu A. Neuralgic amyotrophy associated with hepatitis E virus (HEV) infection: a case report. Acta Neurol Belg. (2017) 117:555&#x2013;7. 10.1007/s13760-016-0642-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-016-0642-1</ArticleId><ArticleId IdType="pubmed">27095100</ArticleId></ArticleIdList></Reference><Reference><Citation>Njabom CN, Gilbert A, Brasseur E, Zandona R, Ghuysen A, D'Orio V. Parsonage-turner syndrome as a rare extrahepatic complication of hepatitis E infection. Eur J Case Rep Intern Med. (2019) 6:001208. 10.12890/2019_001208</Citation><ArticleIdList><ArticleId IdType="doi">10.12890/2019_001208</ArticleId><ArticleId IdType="pmc">PMC6726346</ArticleId><ArticleId IdType="pubmed">31508389</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhardt O, Kuker W, Dichgans J, Weller M. HSV-2 sacral radiculitis (Elsberg syndrome). Neurology. (2004) 63:758&#x2013;9. 10.1212/01.WNL.0000134652.51657.10</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000134652.51657.10</ArticleId><ArticleId IdType="pubmed">15326269</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. . Varicella zoster virus infection. Nat Rev Dis Primers. (2015) 1:15016. 10.1038/nrdp.2015.16</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2015.16</ArticleId><ArticleId IdType="pmc">PMC5381807</ArticleId><ArticleId IdType="pubmed">27188665</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishell JH, Applebaum EL. Ramsay-hunt syndrome in a patient with HIV infection. Otolaryngol&#x2013;Head Neck Surg. (1990) 102:177&#x2013;9. 10.1177/019459989010200215</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/019459989010200215</ArticleId><ArticleId IdType="pubmed">2113244</ArticleId></ArticleIdList></Reference><Reference><Citation>Adour KK. Otological complications of herpes zoster. Ann Neurol. (1994) 35:S62&#x2013;4. 10.1002/ana.410350718</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410350718</ArticleId><ArticleId IdType="pubmed">8185302</ArticleId></ArticleIdList></Reference><Reference><Citation>Moodley A, Swanson J, Grose C, Bonthius DJ. Severe herpes zoster following varicella vaccination in immunocompetent young children. J Child Neurol. (2019) 34:184&#x2013;8. 10.1177/0883073818821498</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073818821498</ArticleId><ArticleId IdType="pmc">PMC6376897</ArticleId><ArticleId IdType="pubmed">30628536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol. (2014) 12:197&#x2013;210. 10.1038/nrmicro3215</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3215</ArticleId><ArticleId IdType="pmc">PMC4066823</ArticleId><ArticleId IdType="pubmed">24509782</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenson HB. Epstein-Barr Virus. Pediatrics Rev. (2011) 32:375&#x2013;83. 10.1542/pir.32.9.375</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/pir.32.9.375</ArticleId><ArticleId IdType="pubmed">21885661</ArticleId></ArticleIdList></Reference><Reference><Citation>Majid A, Galetta SL, Sweeney CJ, Robinson C, Mahalingam R, Smith J, et al. . Epstein&#x2013;Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain. (2002) 125:159&#x2013;65. 10.1093/brain/awf010</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awf010</ArticleId><ArticleId IdType="pubmed">11834601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavin C, Langan Y, Hutchinson M. Cranial and peripheral neuropathy due to Epstein-Barr virus infection. Postgrad Med J. (1997) 73:419&#x2013;20. 10.1136/pgmj.73.861.419</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.73.861.419</ArticleId><ArticleId IdType="pmc">PMC2431413</ArticleId><ArticleId IdType="pubmed">9338028</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorris CB, Gallagher D, Black M. Glandular fever and Epstein-Barr virus-related polyneuropathy: a life-threatening complication. BMJ Case Rep. (2020) 13:e235678. 10.1136/bcr-2020-235678</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-235678</ArticleId><ArticleId IdType="pmc">PMC7604776</ArticleId><ArticleId IdType="pubmed">33127726</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett JL, Mahalingam R, Wellish MC, Gilden DH. Epstein-barr virus-associated acute autonomic neuropathy. Ann Neurol. (1996) 40:453&#x2013;5. 10.1002/ana.410400316</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410400316</ArticleId><ArticleId IdType="pubmed">8797536</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DI, Daube JR. Subacute sensory neuropathy associated with Epstein-Barr virus. Muscle Nerve. (1999) 22:1607&#x2013;10. 10.1002/(SICI)1097-4598(199911)22:11&amp;lt;1607::AID-MUS21&amp;gt;3.0.CO;2-J</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199911)22:11&amp;lt;1607::AID-MUS21&amp;gt;3.0.CO;2-J</ArticleId><ArticleId IdType="pubmed">10514244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai K, Kuwabara S, Mori M, Arai K, Yamamoto T, Hattori T. Leukocytoclastic-vasculitic neuropathy associated with chronic Epstein-Barr virus infection. Muscle Nerve. (2003) 27:113&#x2013;6. 10.1002/mus.10287</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10287</ArticleId><ArticleId IdType="pubmed">12508305</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, Sunwoo JS, Kwon KY, Lee KB, Ahn MY, Roh H. Guillain-Barr&#xe9; syndrome supervening on meningitis in primary Epstein-Barr virus infection. Ann Clin Neurophysiol. (2019) 21:48&#x2013;52. 10.14253/acn.2019.21.1.48</Citation><ArticleIdList><ArticleId IdType="doi">10.14253/acn.2019.21.1.48</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro D, Galli V, Simone AM, Bedin R, Vitetta F, Merelli E, et al. . Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barr&#xe9; syndrome. J Neurovirol. (2017) 23:329&#x2013;34. 10.1007/s13365-016-0493-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-016-0493-9</ArticleId><ArticleId IdType="pubmed">27878471</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Xiong J, Xue Y, Wang J, Zhu X, Zheng X, et al. . An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection. Medicine. (2021) 100:e24451. 10.1097/MD.0000000000024451</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000024451</ArticleId><ArticleId IdType="pmc">PMC7870176</ArticleId><ArticleId IdType="pubmed">33592894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanna A, Nasseri M, Kakara M, Elsayed M. Epstein-Barr virus driven acute motor axonal neuropathy with central demyelination following stem-cell transplant (1740). Neurology. (2020) 94:S1740.</Citation></Reference><Reference><Citation>Cabrera Muras A, Carmona-Abell&#xe1;n MM, Coll&#xed;a Fern&#xe1;ndez A, Uterga Valiente JM, Ant&#xf3;n M&#xe9;ndez L, Garc&#xed;a-Monc&#xf3; JC. Bilateral facial nerve palsy associated with COVID-19 and Epstein&#x2013;Barr virus co-infection. Eur J Neurol. (2021) 28:358&#x2013;60. 10.1111/ene.14561</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14561</ArticleId><ArticleId IdType="pmc">PMC7537085</ArticleId><ArticleId IdType="pubmed">32997868</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor GH. Cytomegalovirus. Am Fam Physician. (2003) 67:519&#x2013;24. Available Online At: https://www.cfp.ca/content/63/5/365.long</Citation><ArticleIdList><ArticleId IdType="pubmed">12588074</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths PD, Whitley RJ. Cytomegalovirus. In: Practical Guidelines in Antiviral Therapy. Elsevier. (2002). 10.1016/B978-044450884-3/50007-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-044450884-3/50007-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier PA, Stephan KT, Blatt SP. Cytomegalovirus polyradiculopathy in HIV-infected patients. J Gen Intern Med. (1996) 11:47&#x2013;9. 10.1007/BF02603486</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02603486</ArticleId><ArticleId IdType="pubmed">8691287</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz H, Enders G. Cytomegalovirus as a frequent cause of Guillain-Barr&#xe9; syndrome. J Med Virol. (1977) 1:21&#x2013;7. 10.1002/jmv.1890010105</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890010105</ArticleId><ArticleId IdType="pubmed">204737</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlikowski D, Porcher R, Sivadon-Tardy V, Quincampoix JC, Raphael JC, Durand MC, et al. . Guillain-Barre syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis. (2011) 52:837&#x2013;44. 10.1093/cid/cir074</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cir074</ArticleId><ArticleId IdType="pubmed">21427390</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva CT, Silva S, Silva MJ, Almeida AF, Fonseca J, Melo C, et al. . Guillain-Barr&#xe9; Syndrome in a Teenage Girl: A Severe Case With Anti-GM2 Antibodies Associated With Acute CMV Infection and Literature Review. Clin Pediatr. (2020) 59:300&#x2013;4. 10.1177/0009922819898186</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0009922819898186</ArticleId><ArticleId IdType="pubmed">31888351</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassis-Ghavami F, Curlin M, Geise R, Duerr A. Human immunodeficiency virus. In: Vaccines for Biodefense and Emerging and Neglected Diseases. Amsterdam. (2009). 10.1016/B978-0-12-369408-9.00025-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-369408-9.00025-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kranick SM, Nath A. Neurologic Complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. CONTINUUM: Lifelong Learn Neurol. (2012) 18:1319&#x2013;37. 10.1212/01.CON.0000423849.24900.ec</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.CON.0000423849.24900.ec</ArticleId><ArticleId IdType="pmc">PMC3760534</ArticleId><ArticleId IdType="pubmed">23221843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawde AK, Emmady PD. HIV-1 Associated Progressive Polyradiculopathy. Tampa, FL: StatPearls Publishing; (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">32965844</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraci AP, Simpson DM. Neurological manifestations of HIV-1 infection in the HAART era. Compreh Ther. (2001) 27:232&#x2013;41. 10.1007/s12019-001-0020-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12019-001-0020-6</ArticleId><ArticleId IdType="pubmed">11569325</ArticleId></ArticleIdList></Reference><Reference><Citation>Keswani SC, Jack C, Zhou C, Hoke A. Establishment of a rodent model of HIV-associated sensory neuropathy. J Neurosci. (2006) 26:10299&#x2013;304. 10.1523/JNEUROSCI.3135-06.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3135-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674617</ArticleId><ArticleId IdType="pubmed">17021185</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato AA, Ropper AH. Sensory ganglionopathy. N Engl J Med. (2020) 383:1657&#x2013;62. 10.1056/NEJMra2023935</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2023935</ArticleId><ArticleId IdType="pubmed">33085862</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahic M, Smith RA, Gibbs CJ, Garruto RM, Tourtellotte WW, Cash E. Detection of picornavirus sequences in nervous tissue of amyotrophic lateral sclerosis and control patients. Ann Neurol. (1985) 18:337&#x2013;43. 10.1002/ana.410180311</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410180311</ArticleId><ArticleId IdType="pubmed">2996416</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HI, Shih SR. Neurotropic enterovirus infections in the central nervous system. Viruses. (2015) 7:6051&#x2013;66. 10.3390/v7112920</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112920</ArticleId><ArticleId IdType="pmc">PMC4664993</ArticleId><ArticleId IdType="pubmed">26610549</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasina M, Domanska A, Palm K, Butcher S. Human picornaviruses associated with neurological diseases and their neutralization by antibodies. J General Virology. (2017) 98:1145&#x2013;58. 10.1099/jgv.0.000780</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000780</ArticleId><ArticleId IdType="pubmed">28631594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cermelli C, Vinceti M, Beretti F, Pietrini V, Nacci G, Pietrosemoli P, et al. . Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7. Eur J Epidemiol. (2003) 18:123&#x2013;7. 10.1023/A:1023067728557</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1023067728557</ArticleId><ArticleId IdType="pubmed">12733833</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker MP, Schlaberg R, Hays AP, Bowser R, Lipkin WI. Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients. Ann Neurol. (2001) 49:249&#x2013;53. 10.1002/1531-8249(20010201)49:2&amp;lt;249::AID-ANA46&amp;gt;3.0.CO;2-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(20010201)49:2&amp;lt;249::AID-ANA46&amp;gt;3.0.CO;2-3</ArticleId><ArticleId IdType="pubmed">11221802</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGowan DJL, Scelsa SN, Waldron M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. (2001) 57:1094&#x2013;7. 10.1212/WNL.57.6.1094</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.6.1094</ArticleId><ArticleId IdType="pubmed">11571341</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfahad T, Nath A. Retroviruses and amyotrophic lateral sclerosis. Antiviral Res. (2013) 99:180&#x2013;7. 10.1016/j.antiviral.2013.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.05.006</ArticleId><ArticleId IdType="pmc">PMC3723705</ArticleId><ArticleId IdType="pubmed">23707220</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinges WL, Witherspoon SR, Itani KM, Garg A, Peterson DM. Blepharoptosis and External Ophthalmoplegia Associated with Long-Term Antiretroviral Therapy. Clin Infect Dis. (2008) 47:845&#x2013;52. 10.1086/591202</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591202</ArticleId><ArticleId IdType="pubmed">18687051</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G, Sirrs S, Wade NK, Mezei MM. Multisystem disorder in late-onset chronic progressive external ophthalmoplegia. Canad J Neurol Sci. (2011) 38:119&#x2013;23. 10.1017/S031716710001115X</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S031716710001115X</ArticleId><ArticleId IdType="pubmed">21156440</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzaki T, Nakagawa M, Nagai M, Nobuhara Y, Usuku K, Higuchi I, et al. . HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol. (2000) 6:544&#x2013;8. 10.3109/13550280009091955</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13550280009091955</ArticleId><ArticleId IdType="pubmed">11175327</ArticleId></ArticleIdList></Reference><Reference><Citation>Toufaily C, Landry S, Leib-Mosch C, Rassart E, Barbeau B. Activation of LTRs from different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators. Viruses. (2011) 3:2146&#x2013;59. 10.3390/v3112146</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3112146</ArticleId><ArticleId IdType="pmc">PMC3230845</ArticleId><ArticleId IdType="pubmed">22163338</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuura E, Umehara F, Nose H, Higuchi I, Matsuoka E, Izumi K, et al. . Inclusion Body Myositis Associated With Human T-Lymphotropic Virus-Type I Infection. J Neuropathol Exper Neurol. (2008) 67:41&#x2013;9. 10.1097/nen.0b013e31815f38b7</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31815f38b7</ArticleId><ArticleId IdType="pubmed">18091562</ArticleId></ArticleIdList></Reference><Reference><Citation>Dervan E, Bhattacharyya DD, McAuliffe JD, Khan FH, Glynn SA. Ancient Adversary &#x2013; HERV-K (HML-2) in Cancer. Front Oncol. (2021) 11:658489. 10.3389/fonc.2021.658489</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.658489</ArticleId><ArticleId IdType="pmc">PMC8155577</ArticleId><ArticleId IdType="pubmed">34055625</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Montojo M, Fathi S, Norato G, Smith BR, Rowe DB, Kiernan MC, et al. . Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy. J Neurol Sci. (2021) 423:117358. 10.1016/j.jns.2021.117358</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117358</ArticleId><ArticleId IdType="pmc">PMC8009857</ArticleId><ArticleId IdType="pubmed">33653604</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J, Harz C, Sanchez L, Pereira GC, Maldener E, Heras SR, et al. . Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins. Mol Neurodegener. (2018) 13:39. 10.1186/s13024-018-0275-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0275-3</ArticleId><ArticleId IdType="pmc">PMC6091006</ArticleId><ArticleId IdType="pubmed">30068350</ArticleId></ArticleIdList></Reference><Reference><Citation>Garson JA, Usher L, Al-Chalabi A, Huggett J, Day EF, McCormick AL. Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis. Acta Neuropathol Commun. (2019) 7:45. 10.1186/s40478-019-0698-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0698-2</ArticleId><ArticleId IdType="pmc">PMC6421708</ArticleId><ArticleId IdType="pubmed">30885274</ArticleId></ArticleIdList></Reference><Reference><Citation>Rex C, Nadeau MJ, Douville R, Schellenberg K. Expression of human endogenous retrovirus-k in spinal and bulbar muscular atrophy. Front Neurol. (2019) 10:968. 10.3389/fneur.2019.00968</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00968</ArticleId><ArticleId IdType="pmc">PMC6738134</ArticleId><ArticleId IdType="pubmed">31551920</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oosterhout C, Hall N, Ly H, Tyler KM. COVID-19 evolution during the pandemic &#x2013; Implications of new SARS-CoV-2 variants on disease control and public health policies. Virulence. (2021) 12:507&#x2013;8. 10.1080/21505594.2021.1877066</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2021.1877066</ArticleId><ArticleId IdType="pmc">PMC7849743</ArticleId><ArticleId IdType="pubmed">33494661</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucott JN, Rebman AW. Long-haul COVID: heed the lessons from other infection-triggered illnesses. Lancet. (2021) 397:967&#x2013;8. 10.1016/S0140-6736(21)00446-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00446-3</ArticleId><ArticleId IdType="pmc">PMC7952095</ArticleId><ArticleId IdType="pubmed">33684352</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al. . Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. (2021) 76:399&#x2013;401. 10.1136/thoraxjnl-2020-216086</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al. . Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infection. (2021) 82:378&#x2013;83. 10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankisi H, Tankisi A, Harbo T, Markvardsen LK, Andersen H, Pedersen TH. Critical illness myopathy as a consequence of Covid-19 infection. Clin Neurophysiol. (2020) 131:1931&#x2013;2. 10.1016/j.clinph.2020.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7834604</ArticleId><ArticleId IdType="pubmed">32619798</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan M v, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmakidis C, Dimachkie MM, Pasnoor M, Barohn RJ. Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part I: Tradit Agents Muscle Nerve. (2020) 61:5&#x2013;16. 10.1002/mus.26708</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26708</ArticleId><ArticleId IdType="pubmed">31509257</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmakidis C, Dimachkie MM, Pasnoor M, Barohn RJ. Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part II: New Novel Agents Muscle Nerve. (2020) 61:17&#x2013;25. 10.1002/mus.26711</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26711</ArticleId><ArticleId IdType="pubmed">31531874</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu S, Jacobson R. Structured review of opportunistic infections in neuromuscular disease (1252). Neurology. (2021) 96:1252.</Citation></Reference><Reference><Citation>Canada MD. What you need to know about Covid-19. (2020). Available online at: https://muscle.ca/covid-19/what-you-need-to-know-about-covid-19/ (accessed June 15, 2021).</Citation></Reference><Reference><Citation>Minotti C, Tirelli F, Barbieri E, Giaquinto C, Don&#xe0; D. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. J Infect. (2020) 81:e61&#x2013;6. 10.1016/j.jinf.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7179496</ArticleId><ArticleId IdType="pubmed">32335173</ArticleId></ArticleIdList></Reference><Reference><Citation>Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D. Regulation of inflammation by microbiota interactions with the host. Nat Immunol. (2017) 18:851&#x2013;60. 10.1038/ni.3780</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3780</ArticleId><ArticleId IdType="pmc">PMC5800875</ArticleId><ArticleId IdType="pubmed">28722709</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>